Detalles de la búsqueda
1.
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer.
Clin Chem
; 68(6): 837-847, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35312747
2.
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer.
Eur Urol Focus
; 9(6): 983-991, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37105783
3.
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8.
Clin Cancer Res
; 27(21): 5931-5938, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34380638
4.
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors.
Eur J Cancer
; 152: 78-89, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34090143
5.
Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-positive, HER2-negative Breast Cancer Patients.
Cancers (Basel)
; 12(5)2020 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369904
6.
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study.
Clin Cancer Res
; 26(3): 623-631, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31641007
7.
Disappearance of phantom pain after focal brain infarction.
Pain
; 32(3): 285-287, 1988 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-3362565
8.
Reliability and acceptance of the mini-clinical evaluation exercise as a performance assessment of practicing physicians.
Acad Med
; 84(10 Suppl): S113-5, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19907370
Resultados
1 -
8
de 8
1
Próxima >
>>